Overview

Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes

Status:
Completed
Trial end date:
2002-09-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: Determine the effectiveness of the combined use of clotrimazole and hydroxyurea on a specific panel of red cell characteristics in patients with sickle cell syndromes.
Phase:
N/A
Details
Lead Sponsor:
Boston Children's Hospital
Boston Children’s Hospital
Treatments:
Clotrimazole
Hydroxyurea
Miconazole